USANA Health Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Common Stock And Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2017


	Quarter Ended		Nine Months Ended
	October 1,	September 30,	October 1,	September 30,
	2016	2017	2016	2017

Net earnings available to common shareholders	$ 30,098	$ 23,769	$ 78,159	$ 68,386


Weighted average common shares outstanding - basic	24,178	24,283	24,112	24,462

Dilutive effect of in-the-money equity awards	872	305	938	409

Weighted average common shares outstanding - diluted	25,050	24,588	25,050	24,871


Earnings per common share from net earnings - basic	$ 1.24	$ 0.98	$ 3.24	$ 2.80

Earnings per common share from net earnings - diluted	$ 1.20	$ 0.97	$ 3.12	$ 2.75


Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that
their effect would be anti-dilutive:
	Quarter Ended		Nine Months Ended
	October 1,	September 30,	October 1,	September 30,
	2016	2017	2016	2017
	2,309	2,035	2,236	2,091